3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 2, 2010, Pages 273-278

  Goel, Amit ^a   Ahmad, Farhan Jalees ^b   Singh, Raman Mohan ^a   Singh, Gyanendra Nath ^b  

^a Central Indian Pharmacopoeia Laboratory   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

3 acetyl 11 keto boswellic acid; Anti arthritic; N isopropylacrylamide; Polymeric nanomicelles; Transdermal delivery

Indexed keywords

1 VINYL 2 PYRROLIDINONE; 3 ACETYL 11 KETO BETA BOSWELLIC ACID; ACRYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; POLY(N ISOPROPYLACRYLAMIDE); UNCLASSIFIED DRUG; ACETYL-11-KETOBOSWELLIC ACID; GEL; MICELLE; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG INHIBITION; DRUG PENETRATION; DRUG RELEASE; ENCAPSULATION; GEL; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; MALE; MICELLE; MOUSE; NONHUMAN; POLYMERIZATION; RAT; SKIN PERMEABILITY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; ARTHRITIS, EXPERIMENTAL; CHEMISTRY; DRUG EFFECTS; EDEMA; LIGHT; METABOLISM; PARTICLE SIZE; RADIATION SCATTERING; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE PROPERTY; TOPICAL DRUG ADMINISTRATION; TOXICITY TESTING; WISTAR RAT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; EDEMA; GELS; LIGHT; MALE; MICE; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; SCATTERING, RADIATION; SKIN; SKIN ABSORPTION; SKIN IRRITANCY TESTS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TRITERPENES; IN VITRO TECHNIQUES;

EID: 77949588645     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.02.0016     Document Type: Article

References (31)

1. Yu S et al. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med 1998 64 : 328 331
2. Liu JJ et al. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Br J Pharmacol 2006 148 : 1099 1107
3. Huang MT et al. Anti-tumor and anti-carcinogenic activities of triterpenoids, beta-boswellic acid. Biofactors 2000 13 : 225 230
4. Bishnoi M et al. Analgesic activity of acetyl-11-keto-β-boswellic acid, a 5-lipoxygenase enzyme inhibitor. Indian J Pharmacol 2005 37 : 255 256
5. Menon MK, Kar A. Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med 1971 19 : 333 341
6. Gupta I et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998 3 : 511 514
7. Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med 2006 72 : 1100 1116
8. Dahmen U et al. Boswellic acid, a potent anti-inflammatory drug, inhibits rejection to the same extent as high dose steroids. Transplant Proc 2001 33 : 539 541
9. Singh S et al. Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 2008 15 : 400 407
10. Sharma ML et al. Antiarthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol 1989 11 : 647 652
11. Gupta OP et al. Application of papaya latex-induced rat paw inflammation: model for evaluation of slowly acting antiarthritic drugs. J Pharmacol Toxicol Methods 1994 31 : 95 98
12. Kimmatkar N et al. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine 2003 10 : 3 7
13. Gupta I et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 2001 67 : 391 395
14. Gerhardt H et al. Therapy of active Crohn disease with Boswellia serrata extract H-15. Z Gastroenrol 2001 39 : 11 17
15. Pandey RS et al. Extract of gum resin of Boswellia serrata L. inhibits lipopolysaccaride induced nitric oxide production in rat macrophages along with hypolipidemic property. Indian J Exp Biol 2005 43 : 509 516
16. Sailer ER et al. Characterization of an acetyl-11-keto-β-boswellic acid and arachidonate binding regulatory site of 5-lipoxygenase using photoaffinity labeling. Eur J Biochem 1998 256 : 364 368
17. Safayhi H et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992 261 : 1143 1146
18. Safayhi H et al. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Mol Pharmacol 1995 47 : 1212 1216
19. Sharma S et al. Pharmacokinetics study of 11-keto-β-boswellic acid. Phytomedicine 2004 11 : 255 260
20. Kaunzinger A et al. Determination of 11-keto-β-boswellic acid in human plasma. J Pharm Biomed Anal 2002 28 : 729 739
21. Krueger P et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos 2008 36 : 1135 1142
22. Karlina MV et al. Bioavailability of boswellic acids: in vitro/in vivo correlation. Pharm Chem J 2007 41 : 569 572
23. Gokaraju GR et al. Process for producing a fraction enriched up to 100% of 3-o-acetyl-11-keto-beta boswellic acid from an extract containing a mixture of boswellic acids. United States Patent Application Publication (2004) US 2004/0073060 A1
24. Goel A et al. Development and validation of a stability-indicating HPTLC method for analysis of 3-acetyl-11-keto-β-boswellic acid in a herbal extract and a nanoparticles formulation. Acta Chromatographica 2008 20 : 497 511
25. Kobayashi D et al. Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with 1-menthol-ethanol system on hairless rat and human skin. Biol Pharm Bull 1993 16 : 254 258
26. Tojo K et al. Influence of donor solution upon skin permeation of drug. J Chem Eng Jpn 1986 19 : 153 155
27. Baboota S et al. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 2007 57 : 315 332
28. Shakeel F et al. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech 2007 8 : E1 E9
29. Van Abbe N et al. Exaggerated exposure in topical irritancy and sensitization testing. J Soc Cosmet Chem 1975 26 : 173 187
30. Winter CA et al. Carrageenan induced edema in hind paw of rat as an assay for anti-inflammatory drugs. Proc Soc Biol Med 1962 11 : 502 507
31. Newbould BB. Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Br J Pharmacol 1963 21 : 127 136